TNF Pharmaceuticals (TNFA) Competitors $0.05 -0.02 (-25.32%) As of 10:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. HCWB, KTTA, THAR, VYNE, BCTX, AEZS, SPRB, TTNP, CPHI, and REVBShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include HCW Biologics (HCWB), Pasithea Therapeutics (KTTA), Tharimmune (THAR), VYNE Therapeutics (VYNE), Briacell Therap (BCTX), Aeterna Zentaris (AEZS), Spruce Biosciences (SPRB), Titan Pharmaceuticals (TTNP), China Pharma (CPHI), and Revelation Biosciences (REVB). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors HCW Biologics Pasithea Therapeutics Tharimmune VYNE Therapeutics Briacell Therap Aeterna Zentaris Spruce Biosciences Titan Pharmaceuticals China Pharma Revelation Biosciences TNF Pharmaceuticals (NASDAQ:TNFA) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Do analysts prefer TNFA or HCWB? HCW Biologics has a consensus price target of $35.00, indicating a potential upside of 499.83%. Given HCW Biologics' stronger consensus rating and higher probable upside, analysts plainly believe HCW Biologics is more favorable than TNF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TNFA or HCWB more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to HCW Biologics' net margin of -1,368.55%. HCW Biologics' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -69.21% -33.98% HCW Biologics -1,368.55%N/A -40.72% Does the media favor TNFA or HCWB? In the previous week, HCW Biologics had 6 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 10 mentions for HCW Biologics and 4 mentions for TNF Pharmaceuticals. HCW Biologics' average media sentiment score of 0.50 beat TNF Pharmaceuticals' score of -0.06 indicating that HCW Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TNF Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HCW Biologics 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings and valuation, TNFA or HCWB? TNF Pharmaceuticals has higher earnings, but lower revenue than HCW Biologics. HCW Biologics is trading at a lower price-to-earnings ratio than TNF Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$23.36M-$2.31-0.02HCW Biologics$2.57M4.88-$30.02M-$14.04-0.42 Which has more risk & volatility, TNFA or HCWB? TNF Pharmaceuticals has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Do insiders & institutionals have more ownership in TNFA or HCWB? 9.6% of TNF Pharmaceuticals shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 0.5% of TNF Pharmaceuticals shares are held by company insiders. Comparatively, 42.7% of HCW Biologics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryHCW Biologics beats TNF Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$652K$2.50B$5.75B$9.76BDividend YieldN/A1.68%3.95%4.03%P/E Ratio-0.0222.7431.3126.52Price / SalesN/A545.88439.11154.97Price / CashN/A177.0937.7359.36Price / Book0.136.1110.536.64Net Income-$23.36M$32.94M$3.27B$265.47M7 Day PerformanceN/A-0.99%1.35%0.50%1 Month PerformanceN/A2.56%6.13%2.47%1 Year PerformanceN/A11.56%49.95%22.11% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.05-25.3%N/AN/A$652KN/A-0.026News CoverageStock SplitGap DownHCWBHCW Biologics2.5141 of 5 stars$3.83-6.4%$35.00+814.1%-71.0%$5.49M$2.57M-0.1640KTTAPasithea Therapeutics1.0844 of 5 stars$0.73+2.0%N/A-81.6%$5.39MN/A-0.103News CoveragePositive NewsTHARTharimmune3.4599 of 5 stars$1.26-3.1%$17.00+1,249.2%+107.9%$5.32MN/A-0.212Gap UpVYNEVYNE Therapeutics2.2284 of 5 stars$0.35+1.2%$6.25+1,696.0%-81.7%$5.29M$500K-0.3930BCTXBriacell Therap2.8746 of 5 stars$0.77+1.0%$32.00+4,050.5%-93.9%$5.14MN/A-0.098Trending NewsAnalyst RevisionAEZSAeterna ZentarisN/A$2.85-18.6%N/A-17.3%$5.11M$2.37M-0.1920Gap DownHigh Trading VolumeSPRBSpruce Biosciences1.706 of 5 stars$9.01+3.0%$131.25+1,356.7%-78.7%$5.06M$4.91M-9.5920Gap UpTTNPTitan Pharmaceuticals0.4377 of 5 stars$5.34+8.2%N/A-36.7%$4.72M$180K-1.7610CPHIChina PharmaN/A$1.44+1.0%N/A-92.9%$4.71M$4.30M0.00250Gap UpREVBRevelation Biosciences0.2564 of 5 stars$2.77+2.2%N/A-94.8%$4.71MN/A-0.0410Gap Up Related Companies and Tools Related Companies HCW Biologics Alternatives Pasithea Therapeutics Alternatives Tharimmune Alternatives VYNE Therapeutics Alternatives Briacell Therap Alternatives Aeterna Zentaris Alternatives Spruce Biosciences Alternatives Titan Pharmaceuticals Alternatives China Pharma Alternatives Revelation Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access